Bay Navigator  |  Clinical news

Changes to Cellulitis Pathway on Bay Navigator

In order to line up with best practice and other DHBs, the Cellulitis pathway on the Bay Navigator site has been updated.

Important changes include the removal of all IV options, i.e. a move to all-oral regimes, updates to antibiotic choices, as well as some new information resources. Note that the Acute Demand funding will not change, so 48-hour follow-up visits for grades 2 and 3 are still funded.

Click here to check out the updated pathway. You can also view a recording of Dr Kate Grimwade's presentation here.

Please let us know if you have any feedback




Last updated : Monday, May 03, 2021

Disclaimer: This site is intended to be flexible and frequently updated. While every effort has been made to ensure accuracy, all information should be verified.